Literature DB >> 27079756

Recent advances in the diagnosis and treatment of polymyalgia rheumatica.

Francesco Muratore1, Giulia Pazzola1, Nicolò Pipitone1, Carlo Salvarani1.   

Abstract

INTRODUCTION: Polymyalgia rheumatica is one of the most common rheumatic inflammatory disorders in people older than 50 years characterized by aching and prolonged morning stiffness in the shoulder and pelvic girdle and neck.. AREAS COVERED: In this review, we will focus on recent advances on the diagnosis and management of PMR. Expert commentary: Controversy exist whether PMR represent a single entity disease or is an umbrella term that comprises a clinical presentation common to a range of related conditions (polymyalgic syndrome). To date there are no specific diagnostic tests, and the diagnosis remains clinical, although ultrasonography, positron emission tomography scan and the recent ACR/EULAR classification criteria may help to confirm the clinical diagnosis. A step-wise process for the diagnosis of PMR has been proposed. Low-dose steroids are highly effective in the majority of patients and remain the mainstay of treatment, but relapses occur in about 50% of patients and glucocorticoid related adverse event are common. The steroid sparing effects of the immunosuppressive treatment evaluated to date are unclear.

Entities:  

Keywords:  PET; Polymyalgia rheumatica; classification criteria; giant cell arteritis; glucocorticoids; recommendations; tocilizumab; ultrasonography

Mesh:

Substances:

Year:  2016        PMID: 27079756     DOI: 10.1080/1744666X.2016.1178572

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  4 in total

Review 1.  [S3 guidelines on treatment of polymyalgia rheumatica : Evidence-based guidelines of the German Society of Rheumatology (DGRh), the Austrian Society of Rheumatology and Rehabilitation (ÖGR) and the Swiss Society of Rheumatology (SGT) and participating medical scientific specialist societies and other organizations].

Authors:  F Buttgereit; T Brabant; H Dinges; I Hiemer; M Kaplani; U Kiltz; D Kyburz; A Reißhauer; M Schneider; C Weseloh; C Dejaco
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

2.  An Unusual Side Effect of the COVID-19 Vaccine: A Possible Trigger of Polymyalgia Rheumatica.

Authors:  Anam Ahmad; Donica L Baker
Journal:  Cureus       Date:  2022-07-06

3.  Polymyalgia rheumatica: A case series from Colombia and analysis of Latin America.

Authors:  Carlos Enrique Toro-Gutiérrez; Carlos A Cañas; Rubén D Mantilla; Santiago Beltrán; Vivian Pastrana-Gonzalez; Milly J Vecino; Mónica Rodriguez-Jimenez; Manuel Rojas
Journal:  J Transl Autoimmun       Date:  2021-08-21

4.  A case report of polymyalgia rheumatica.

Authors:  Iryna Kniazkova; Larysa Shapovalova; Maryna Bogun
Journal:  Reumatologia       Date:  2018-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.